Merck recalls a lot of Vytorin; India's Kilitch says it will partner on a drug plant in Ethiopia;

> Merck ($MRK) is voluntarily recalling one lot of its combo statin Vytorin after a larger-dose tablet was found in a bottle of 10 mg/20mg tablets. Notice

> The FDA has awarded a $4.9 million grant to a Rutgers University-led research consortium to study continuous manufacturing. Report

> Fertin India Private is opening the country's first medicated chewing gum manufacturing plant to make a Nicotine Replacement Therapy. Report

> Indian drugmaker Kilitch Drugs in a filing with the Bombay Stock Exchange said it has formed a joint venture an Ethiopian partner to establish a manufacturing plant in the African country. Report

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.